VIRTUAL REGISTRATION: Psychopharmacology 2025
We invite you to join us Virtually for our 49th Annual Psychopharmacology conference!
NOTE: Thursday ticketed events, and Friday and Saturday evening seminars are NOT included in the virtual registration option. These sessions will NOT be live-streamed.
Engage with Experts.
Elevate Results.
Enhance your Practice.
Please Note: The conference will be held in Easter Daylight Time (EDT)
We invite you to attend the 49th Annual Psychopharmacology Conference virtually! This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics include ADHD, anxiety, bipolar disorder, depression, OCD, psychosis, PTSD, substance use disorders, and much more.
In every session, our faculty share data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, natural medications, combining pharmacologic and psychosocial treatments, and much more.
Most important of all, our faculty focus on how to translate all these insights into your daily practice. This empowers you to optimize your care for patients with psychiatric conditions. That makes our event ideal for professionals in psychiatry, primary care, psychology, and nursing.
You will receive email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the Zoom instructions and attending virtually.
Pricing
3-DAY PSYCHOPHARMACOLOGY CONFERENCE
MDs/Doctoral-Level Professionals:
Super Early Bird Registration (on or before July 25, 2025) $929.00
Early Bird Registration (on or before September 5, 2025) $999.00
Regular Registration (after September 5, 2025) $1049.00
Other Professionals or Trainees:
Super Early Bird Registration (on or before July 25, 2025) $829.00
Early Bird Registration (on or before September 5, 2025) $899.00
Regular Registration (after September 5, 2025) $949.00
Live Registration:
The conference occurs live at the Westin Copley Place in Boston. For more information about in-person attendance and the venue, please visit our live registration page:
Psychopharmacology 2025: Live Registration - Click Here
E-Syllabus
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
No refunds will be issued for refund requests. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition
Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.
Purchase a print copy of our Board Preparation book here!
MOC Self-Assessment Module: Psychopharmacology
As part of recertification requirements, physicians must participate in Maintenance of Certification Program (MOC) activities like this one to cultivate a focus on lifelong learning and competency throughout one’s profession. This module helps you hone in on clinical and practice management skills that are central to quality patient care and improved outcomes for patients.
Target Audience
This program is intended for psychiatrists, psychologists, general and family practice physicians, psychiatric nurses, physician assistants, nurse practitioners, and social workers.
Accreditation pending - please check back for more information.
Learning Objectives
By the end of this program, participants will be able to:
- Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, treatment-resistant, and post-partum depression
- Compare the neurobiology and evidence-based treatment approaches to addiction, anxiety, schizophrenia, and mood disorders
- Review the course and treatment of psychiatric disorders during pregnancy and menopause
- Analyze drug interactions and the pharmacotherapy of adult ADHD and geriatric disorders
- Apply newer strategies in treatment of chemical abuse/dependence
- Analyze evidence-based treatment for psychiatric illness
- Assess the most recent state of the art treatment alternatives
- Assess new therapies and what is on the horizon
- Analyze the use of CBT based techniques
49th Annual Psychopharmacology
OCTOBER 16-19, 2025
Westin copley place
boston
Please check back for full program information.
Faculty
Course Directors:
Maurizio Fava, MD
Jerrold Rosenbaum, MD
Accreditation pending - please check back for more information.